The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. The conference was held on 1 December 2016. It is a joint initiative of the Dermatology Section of...

ver descrição completa

Detalhes bibliográficos
Autores: Zuberbier, Torsten, Giménez Arnau, Anna Maria, Maurer, Marcus
Tipo de documento: artigo
Estado:Versión aceptada para publicación
Data de publicação:2018
País:España
Recursos:Universitat Pompeu Fabra
Repositório:Repositorio Digital de la UPF
OAI Identifier:oai:repositori.upf.edu:10230/35554
Acesso em linha:http://hdl.handle.net/10230/35554
http://dx.doi.org/10.1111/all.13397
Access Level:Acceso aberto
Palavra-chave:Urticaria
Angioedema
Consensus
Evidence-based
Hives
Wheal
id ES_13ce259a1606bb2bf5d2eebda3af5aa7
oai_identifier_str oai:repositori.upf.edu:10230/35554
network_acronym_str ES
network_name_str España
repository_id_str
spelling The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticariaZuberbier, TorstenGiménez Arnau, Anna MariaMaurer, MarcusUrticariaAngioedemaConsensusEvidence-basedHivesWhealThis evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. The conference was held on 1 December 2016. It is a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the EU-founded network of excellence, the Global Allergy and Asthma European Network (GA²LEN), the European Dermatology Forum (EDF) and the World Allergy Organization (WAO) with the participation of 48 delegates of 42 national and international societies. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). Urticaria is a frequent, mast cell-driven disease, presenting with wheals, angioedema, or both. The lifetime prevalence for acute urticaria is approximately 20%. Chronic spontaneous urticaria and other chronic forms of urticaria are disabling, impair quality of life and affect performance at work and school. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms. In addition, it outlines evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria.Wiley20182018info:eu-repo/semantics/articleinfo:eu-repo/semantics/acceptedVersionapplication/pdfapplication/pdfhttp://hdl.handle.net/10230/35554http://dx.doi.org/10.1111/all.13397reponame:Repositorio Digital de la UPFinstname:Universitat Pompeu FabraInglésAllergy. 2018 Jul;73(7):1393-14This is the peer reviewed version of the following article: Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, Ballmer-Weber B, et al. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticarial. Allergy. 2018 Jul;73(7):1393-1414, which has been published in final form at http://dx.doi.org/10.1111/all.13397. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.info:eu-repo/semantics/openAccessoai:repositori.upf.edu:10230/355542026-06-12T07:21:37Z
dc.title.none.fl_str_mv The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
title The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
spellingShingle The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
Zuberbier, Torsten
Urticaria
Angioedema
Consensus
Evidence-based
Hives
Wheal
title_short The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
title_full The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
title_fullStr The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
title_full_unstemmed The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
title_sort The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
dc.creator.none.fl_str_mv Zuberbier, Torsten
Giménez Arnau, Anna Maria
Maurer, Marcus
author Zuberbier, Torsten
author_facet Zuberbier, Torsten
Giménez Arnau, Anna Maria
Maurer, Marcus
author_role author
author2 Giménez Arnau, Anna Maria
Maurer, Marcus
author2_role author
author
dc.subject.none.fl_str_mv Urticaria
Angioedema
Consensus
Evidence-based
Hives
Wheal
topic Urticaria
Angioedema
Consensus
Evidence-based
Hives
Wheal
description This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. The conference was held on 1 December 2016. It is a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the EU-founded network of excellence, the Global Allergy and Asthma European Network (GA²LEN), the European Dermatology Forum (EDF) and the World Allergy Organization (WAO) with the participation of 48 delegates of 42 national and international societies. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). Urticaria is a frequent, mast cell-driven disease, presenting with wheals, angioedema, or both. The lifetime prevalence for acute urticaria is approximately 20%. Chronic spontaneous urticaria and other chronic forms of urticaria are disabling, impair quality of life and affect performance at work and school. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms. In addition, it outlines evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria.
publishDate 2018
dc.date.none.fl_str_mv 2018
2018
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/acceptedVersion
format article
status_str acceptedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10230/35554
http://dx.doi.org/10.1111/all.13397
url http://hdl.handle.net/10230/35554
http://dx.doi.org/10.1111/all.13397
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Allergy. 2018 Jul;73(7):1393-14
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Wiley
publisher.none.fl_str_mv Wiley
dc.source.none.fl_str_mv reponame:Repositorio Digital de la UPF
instname:Universitat Pompeu Fabra
instname_str Universitat Pompeu Fabra
reponame_str Repositorio Digital de la UPF
collection Repositorio Digital de la UPF
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869403699573424128
score 15,812429

Registros relacionados